STAT
MARCH 25, 2025
23andMe might have filed for bankruptcy , but the transformation it brought to health care over nearly two decades is irreversible. I’m a physician, scientist, and advocate for public health. I’ve witnessed how empowering people with knowledge about their own biology drives meaningful health decisions and actions, something millions have now experienced firsthand.
Express Pharma
MARCH 25, 2025
The global cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth rate of 44 per cent, with sales projected to rise from $8.70 billion in 2024 to $76.03 billion in 2030. Significant advancements in treatments for gastrointestinal (GI) disorders are anticipated, driven by innovations from both large and small pharma companies, says GlobalData, a leading data and analytics company.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 25, 2025
Mehmet Oz has been a heart surgeon, a TV show host, an author, and a Senate candidate. On Tuesday, he inched closer to adding CMS administrator to the list. The Senate Finance Committee voted along party lines to send Oz’s nomination to lead the Centers for Medicare and Medicaid Services to the full Senate for a vote, where he’ll likely be confirmed.
Pharma Marketing Network
MARCH 25, 2025
Automation, AI, budget cuts, and evolving digital strategies have prompted a growing question among pharmaceutical marketing teams: Is my pharma marketing job at risk? As companies adapt to more agile workflows and redefine what modern commercialization looks like, the roles of marketing professionals are being evaluated more critically than ever before.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
MARCH 25, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! It was quite a rainy day in Boston yesterday — but at least it wasn’t a cold one. I’m manifesting some sun for today.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Express Pharma
MARCH 25, 2025
Cadila Pharmaceuticals has launched Cadilose, an advanced Lactulose formulation designed to effectively manage constipation and hepatic encephalopathy (HE). Cadilose is a disaccharide-based osmotic laxative, synthesised from galactose and fructose, which increases water retention in the intestines and promotes smooth bowel movements. It also functions as a prebiotic, encouraging the growth of beneficial gut bacteria.
pharmaphorum
MARCH 25, 2025
Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis
The Pharmacist
MARCH 25, 2025
Clade Ia and Ib mpox has been downgraded from a high consequence infectious disease in the UK, public health officials have confirmed. A review by the Advisory Committee on Dangerous Pathogens found that clade I mpox no longer meets the criteria as a high consequence infectious disease defined as having a high mortality rate and […] The post UK downgrades mpox from high consequence infectious disease status appeared first on The Pharmacist.
Pharmaceutical Technology
MARCH 25, 2025
The study will analyse electronic health records of 65- and 66-year olds from the UKs National Health Service (NHS).
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Dive
MARCH 25, 2025
A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a genetic risk factor called lipoprotein(a).
pharmaphorum
MARCH 25, 2025
Explore the latest M&A opportunities in the UK weight loss market, including market access for products like Wegovy and Mounjaro. Stay informed about key trends and opportunities in the industry.
BioPharma Dive
MARCH 25, 2025
The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed geographic atrophy medicines.
pharmaphorum
MARCH 25, 2025
A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharmacy Times
MARCH 25, 2025
Although PBMs claim integration reduces costs and improves efficiency, the reality is more complicatedand often leaves patients footing the bill.
Pharmaceutical Commerce
MARCH 25, 2025
What drivers impact the differences in expenditures?
Pharmaceutical Technology
MARCH 25, 2025
WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on 18 March 2025.
pharmaphorum
MARCH 25, 2025
MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200m upfront
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmaceutical Commerce
MARCH 25, 2025
The latest news for pharma industry insiders.
World Pharma News
MARCH 25, 2025
Among other functions, the NK cells (Natural Killers, a type of lymphocyte forming part of the immune system) have the capacity to detect and eliminate cancer cells. But in some cases they cannot overcome the tumours defense mechanism and the cancer grows. Now, a study published in Nature Immunology, with the involvement of the Hospital del Mar Research Institute, the Universitat Autnoma de Barcelona and the Pompeu Fabra University, proposes a new approach to strengthen NK cells in their fight a
Pharmacy Times
MARCH 25, 2025
If approved, this novel monoclonal antibody therapy could become a standard of care emergency option for patients with acute myocardial infarction, which affects millions in the United States and across the world.
pharmaphorum
MARCH 25, 2025
EVERSANA discuss 5 effective strategies for overcoming pricing and access challenges in the European healthcare landscape. Learn about HTA, risk-sharing, data utilisation, orphan drugs, and more.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
PharmaTech
MARCH 25, 2025
Under the agreement, AstraZeneca will use Alteogens proprietary hyaluronidase platform technology to develop and commercialize subcutaneous formulations of multiple oncology assets in its portfolio.
PharmExec
MARCH 25, 2025
Under terms of the license agreement, Novo Nordisk will acquire the rights to develop and commercialize UBT251 outside of China for obesity and type 2 diabetes for an upfront payment of $200 million.
PharmaTech
MARCH 25, 2025
The contract will support R&D of high-quality APIs for substance use disorders and mental health conditions, starting with synthesis and scale-up of psilocybin, which is derived from mushrooms.
PharmExec
MARCH 25, 2025
Under terms of the deal, Merck will gain global rights to develop, manufacture, and commercialize HRS-5346 for cardiovascular disease, excluding Greater China.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaTech
MARCH 25, 2025
The growing development of new biotherapeutic modalities will rely heavily on automation and progressive technologies.
Pharmaceutical Technology
MARCH 25, 2025
Novo Nordisk has acquired the global rights to United Laboratories triple-agonist weight-loss and diabetes drug in a deal worth up to $2bn.
PharmExec
MARCH 25, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Expert insights. Personalized for you.
326 
Let's personalize your content